Profil
Sherin Al-Safadi currently works at Radiopharm Theranostics Ltd., as Vice President-Medical & Corporate Affairs from 2023.
Dr. Al-Safadi also formerly worked at Bayer Pharmaceuticals Corp., as Director-Global Medical Affairs Oncology Strategy and POINT Biopharma Global, Inc., as Vice President-Medical Affairs.
Dr. Al-Safadi received her graduate degree from McGill University, doctorate degree from Concordia University, and Masters Business Admin degree from John Molson School of Business.
Postes actifs de Sherin Al-Safadi
| Sociétés | Poste | Début |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Directeur Technique/Scientifique/R&D | 24/07/2023 |
Anciens postes connus de Sherin Al-Safadi
| Sociétés | Poste | Fin |
|---|---|---|
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| POIT BIOP | Directeur Technique/Scientifique/R&D | - |
Formation de Sherin Al-Safadi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bayer Pharmaceuticals Corp. | |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
John Molson School of Business
John Molson School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
POINT Biopharma Global, Inc.
POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
















